Authors: Mutlib, A Shockcor, J Chen, SY Espina, R Lin, JR Graciani, N Prakash, S Gan, LS

Citation: A. Mutlib et al., Formation of unusual glutamate conjugates of 1-[3(aminomethyl)phenyl]-N-[3-fluoro-2 '-(methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC 423) and its analogs: The role of gamma-glutamyltranspeptidase in the biotransformation of benzylamines, DRUG META D, 29(10), 2001, pp. 1296-1306

Authors: Mutlib, A Chen, H Shockcor, J Espina, R Chen, S Cao, K Du, A Nemeth, G Prakash, S Gan, LS

Citation: A. Mutlib et al., Characterization of novel glutathione adducts of a non-nucleoside reverse transcriptase inhibitor, (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-3,4-dihydro-2(1H)-quinazolinone (DPC 961), in rats. Possible formation of an oxirene metabolic intermediate from a disubstituted alkyne, CHEM RES T, 13(8), 2000, pp. 775-784

Authors: Mutlib, AE Diamond, S Shockcor, J Way, R Nemeth, G Gan, L Christ, DD

Citation: Ae. Mutlib et al., Mass spectrometric and NMR characterization of metabolites of roxifiban, apotent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor, XENOBIOTICA, 30(11), 2000, pp. 1091-1110

Authors: Mutlib, AE Shockcor, J Espina, R Graciani, N Du, A Gan, LS

Citation: Ae. Mutlib et al., Disposition of glutathione conjugates in rats by a novel glutamic acid pathway: characterization of unique peptide conjugates by liquid chromatography/mass spectrometry and liquid chromatography/NMR, J PHARM EXP, 294(2), 2000, pp. 735-745